<DOC>
	<DOCNO>NCT02008565</DOCNO>
	<brief_summary>The study multi-center , randomize , placebo control trial participant randomize one four group : 1. placebo/usual care ( educational pamphlet ) 2. loperamide/usual care ( educational pamphlet ) 3. placebo/anal exercise biofeedback 4. loperamide/anal exercise biofeedback The primary outcome , change baseline St. Marks ( Vaizey ) Score 24 week , compare treatment group use linear regression .</brief_summary>
	<brief_title>Controlling Anal Incontinence Performing Anal Exercises With Biofeedback Loperamide ( CAPABLe )</brief_title>
	<detailed_description>The goal trial compare use loperamide oral placebo compare use anal sphincter exercise training biofeedback usual care ( educational pamphlet ) treatment woman suffer fecal incontinence ( FI ) . We test follow null hypothesis : 1. difference outcome woman randomize loperamide woman randomize oral placebo treatment FI ; 2. difference outcome woman randomize anal sphincter exercise biofeedback woman randomize usual care ( educational pamphlet ) FI treatment ; 3. difference woman randomize treatment together woman randomize either FI treatment alone ; 4. correlation anal manometry measurement digital anal squeeze strength measure FI severity bother . A supplemental study , Stool Metabolome Microbiome Women Fecal Incontinence CAPABLe , evaluate stool metabolome microbiome woman fecal incontinence unaffected age match control .</detailed_description>
	<mesh_term>Fecal Incontinence</mesh_term>
	<mesh_term>Loperamide</mesh_term>
	<mesh_term>Antidiarrheals</mesh_term>
	<criteria>Age ≥18 year Fecal incontinence define uncontrolled loss liquid solid fecal material occur least monthly last 3 month bothersome enough desire treatment Stool consistency last 3 month include item 1 7 base Bristol Stool form scale Current past diagnosis colorectal anal malignancy Diagnosis inflammatory bowel disease Current history rectovaginal fistula cloacal defect Rectal prolapse ( mucosal full thickness ) Prior removal diversion portion colon rectum Prior pelvic floor abdominal radiation Refusal inability provide write consent Inability conduct telephone interview conduct English Spanish Fecal impaction exam Untreated pelvic organ prolapse beyond hymen ; Patients prolapse beyond hymen currently use pessary eligible Incontinence flatus Has take loperamide ( Imodium® ) diphenoxylate plus atropine ( Lomotil® ) last 30 day Previously receive failed treatment fecal incontinence use loperamide ( Imodium® ) diphenoxylate plus atropine ( Lomotil® ) last 3 month Current supervise anal sphincter exercise/pelvic floor muscle train biofeedback Previously receive failed treatment fecal incontinence use supervised anal sphincter exercise/pelvic floor muscle train biofeedback Previous allergy intolerance loperamide Pregnant , nursing , plan become pregnant end study followup period . Childbirth within last 3 month Currently take antiretroviral drug Neurological disorder know affect continence , include spinal cord injury , advanced multiple sclerosis Parkinson 's disease debilitate stroke Known diagnosis hepatic impairment Chronic abdominal pain absence diarrhea</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Fecal incontinence</keyword>
	<keyword>Loperamide</keyword>
	<keyword>anal exercise</keyword>
	<keyword>biofeedback</keyword>
</DOC>